Skip to Main Content

Paper Details

Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression.
Brain
4
2023
A42, AD, AT(N), Alzheimer Disease, Alzheimer's disease, CSF ptau181, NfL, Participants, amyloid, amyloid- (A)42, neurodegeneration, neurofilament light chain, neuroinflammatory, pTau181, participants, phosphorylated tau, tau
Author NameAffiliation
David M HoltzmanWashington University in St. Louis
David M HoltzmanKnight Alzheimer Disease Research Center, Washington University School of Medicine
David M HoltzmanWashington University in Saint Louis
John C MorrisWashington University in St. Louis
John C MorrisKnight Alzheimer Disease Research Center, Washington University School of Medicine
Beau M AncesWashington University in St. Louis
Beau M AncesWashington University in St. Louis
Beau M AncesWashington University in Saint Louis
Beau M AncesKnight Alzheimer Disease Research Center, Washington University School of Medicine
  • 1 - 9

Datasets

Release 1.2